182 related articles for article (PubMed ID: 1967815)
1. Glucose counterregulation in diabetes secondary to chronic pancreatitis.
Larsen S; Hilsted J; Philipsen EK; Tronier B; Christensen NJ; Damkjaer Nielsen M; Worning H
Metabolism; 1990 Feb; 39(2):138-43. PubMed ID: 1967815
[TBL] [Abstract][Full Text] [Related]
2. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
Popp DA; Shah SD; Cryer PE
J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
[TBL] [Abstract][Full Text] [Related]
3. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
4. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
Cryer PE; Gerich JE
N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus secondary to chronic pancreatitis.
Larsen S
Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
[TBL] [Abstract][Full Text] [Related]
7. Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes mellitus.
White NH; Gingerich RL; Levandoski LA; Cryer PE; Santiago JV
Diabetes; 1985 Sep; 34(9):870-5. PubMed ID: 2993084
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function.
Larsen S; Hilsted J; Tronier B; Worning H
Acta Endocrinol (Copenh); 1988 Jul; 118(3):357-64. PubMed ID: 2899369
[TBL] [Abstract][Full Text] [Related]
9. Impaired response of human pancreatic polypeptide to insulin-induced hypoglycemia in chronic pancreatitis without diabetes mellitus.
Hanafusa T; Toyoshima H; Nonaka K; Tarui S
Endocrinol Jpn; 1982 Oct; 29(5):509-15. PubMed ID: 6763560
[TBL] [Abstract][Full Text] [Related]
10. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
11. Alanine and terbutaline in treatment of hypoglycemia in IDDM.
Wiethop BV; Cryer PE
Diabetes Care; 1993 Aug; 16(8):1131-6. PubMed ID: 8375243
[TBL] [Abstract][Full Text] [Related]
12. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
[TBL] [Abstract][Full Text] [Related]
13. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy.
Dejgaard A; Andersen P; Hvidberg A; Hilsted J
Diabet Med; 1996 Nov; 13(11):983-9. PubMed ID: 8946158
[TBL] [Abstract][Full Text] [Related]
15. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic cholinergic antagonism does not enhance recovery from hypoglycemia in IDDM.
Hvidberg A; Cryer PE
Diabetes Care; 1995 Mar; 18(3):404-7. PubMed ID: 7555487
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.
Towler DA; Havlin CE; Craft S; Cryer P
Diabetes; 1993 Dec; 42(12):1791-8. PubMed ID: 8243825
[TBL] [Abstract][Full Text] [Related]
18. Hormonal, metabolic, and circulatory responses to insulin-induced hypoglycemia in pregnant and nonpregnant women with insulin-dependent diabetes.
Nisell H; Persson B; Hanson U; Lunell NO; Nylund L; Sarby B; Thronström S
Am J Perinatol; 1994 May; 11(3):231-6. PubMed ID: 8048992
[TBL] [Abstract][Full Text] [Related]
19. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
[TBL] [Abstract][Full Text] [Related]
20. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
